Ascitic fluid total protein, a useful marker in non-portal hypertensive ascites

J Gastroenterol Hepatol. 2020 Feb;35(2):271-277. doi: 10.1111/jgh.14768. Epub 2019 Jul 15.

Abstract

Background and aims: Diagnostic performance of ascitic fluid total protein (AFTP) concentration remained unsettled. Our aim was to determine diagnostic value of AFTP in differential diagnosis of causes of ascites.

Methods: Seven hundred four consecutive patients with new-onset ascites were prospectively enrolled in this study.

Results: In the training cohort, diagnostic performance of quantitative AFTP assay was superior to that of Rivalta test in differential diagnosis of ascites. At the predetermined cut-off value of 25 g/L, quantitative AFTP assay was more useful in the differentiation of non-portal hypertensive ascites from portal hypertensive ascites compared with the exudate-transudate classification, area under curve of receiver operating characteristic curve was 0.958. Quantitative AFTP assay was superior to serum-ascites albumin gradient in the detection of non-portal hypertensive ascites, especially malignant ascites and tuberculous peritonitis. In mixed ascites, AFTP was useful in identifying peritoneal lesions.

Conclusions: Ascitic fluid total protein is a useful marker in non-portal hypertensive ascites; thus, it should be determined in diagnostic work-up of the patients with ascites.

Keywords: Rivalta test; ascitic fluid total protein; mixed ascites; non-portal hypertension.

MeSH terms

  • Ascites / diagnosis*
  • Ascites / etiology*
  • Ascitic Fluid / chemistry*
  • Biomarkers / analysis
  • Diagnosis, Differential
  • Humans
  • Hypertension / complications
  • Proteins / analysis*

Substances

  • Biomarkers
  • Proteins